Imatinib Mesylate Induces Necroptotic Cell Death and Impairs Autophagic Flux in Human Cardiac Progenitor Cells. [PDF]
Walmsley R+4 more
europepmc +1 more source
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome–positive chronic phase chronic myeloid leukemia [PDF]
Hagop M. Kantarjian+12 more
openalex +1 more source
A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
The use of imatinib mesylate (Glivec®) (Novartis Pharma AG, Switzerland) that is the drug of choice in treating patients with chronic myeloid leukemia (CML) has increased 7-year survival and improved the prognosis of the disease.
Ol'ga Veniaminovna Stakhina+7 more
doaj
BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells [PDF]
Su Chu+3 more
openalex +1 more source
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis [PDF]
Craig Daniels+6 more
openalex +2 more sources
Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome [PDF]
Jorge E. Cortés+9 more
openalex +1 more source
Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells. [PDF]
Khaing EM+5 more
europepmc +1 more source
Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571) [PDF]
Lara Wohlbold+6 more
openalex +1 more source
Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. [PDF]
Omran MM+5 more
europepmc +1 more source
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [PDF]
Juan Luis Garcı́a+6 more
openalex +1 more source